Deep Bio Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 18

Deep Bio General Information

Description

Developer of deep learning-based medical technology designed to improve reliability and decrease the turnaround time of medical diagnoses. The company uses a convolutional neural network with the input of myriad needle biopsy images to develop the computer-aided detection and diagnosis system for prostate cancer, helping medical professionals to make better-informed decisions that will lead to outcomes for patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 609-613, 27, Digital-ro 33-gil
  • Guro-gu
  • Seoul
  • South Korea
+82
Primary Industry
Decision/Risk Analysis
Corporate Office
  • 609-613, 27, Digital-ro 33-gil
  • Guro-gu
  • Seoul
  • South Korea
+82

Deep Bio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Deep Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
5. Later Stage VC (Series B) 26-Oct-2023 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
3. Later Stage VC (Series B) 03-Aug-2020 Completed Generating Revenue
2. Early Stage VC (Series A) 02-Mar-2018 $5.6M $7.29M Completed Generating Revenue
1. Seed Round 12-Aug-2017 $1.69M $1.69M Completed Generating Revenue
To view Deep Bio’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Deep Bio Patents

Deep Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025198288-A1 Method for annotating biological tissue image with lesion type and computing system for performing same Pending 20-Mar-2024
WO-2025183413-A1 Method for generating pathological diagnosis report for pathological diagnosis case, and computing system for performing same Pending 26-Feb-2024
WO-2025164990-A1 Method for generating representative lesion image of pathological diagnosis case, and computing system for performing same Pending 31-Jan-2024
WO-2025110600-A1 Method for generating representative lesion image of biological tissue image, and computing system for performing same Inactive 23-Nov-2023
WO-2025095396-A1 Method for training deep learning model for pathological image analysis and computing system performing same Inactive 31-Oct-2023
To view Deep Bio’s complete patent history, request access »

Deep Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Deep Bio Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Matter (Consulting Services (B2B)) Accelerator/Incubator
Gencurix Corporation Minority
Korea AI Startup 100 Accelerator/Incubator
Albatross Investment Venture Capital Minority
Daekyo Investment Corporate Venture Capital Minority
You’re viewing 5 of 18 investors. Get the full list »

Deep Bio FAQs

  • When was Deep Bio founded?

    Deep Bio was founded in 2015.

  • Where is Deep Bio headquartered?

    Deep Bio is headquartered in Seoul, South Korea.

  • What is the size of Deep Bio?

    Deep Bio has 8 total employees.

  • What industry is Deep Bio in?

    Deep Bio’s primary industry is Decision/Risk Analysis.

  • Is Deep Bio a private or public company?

    Deep Bio is a Private company.

  • What is Deep Bio’s current revenue?

    The current revenue for Deep Bio is .

  • How much funding has Deep Bio raised over time?

    Deep Bio has raised $8.4M.

  • Who are Deep Bio’s investors?

    Matter (Consulting Services (B2B)), Gencurix, Korea AI Startup 100, Albatross Investment, and Daekyo Investment are 5 of 18 investors who have invested in Deep Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process